Lundbeck
HLUN-B.CO
#2708
Rank
โ‚น617.18 B
Marketcap
โ‚น622.07
Share price
0.19%
Change (1 day)
29.20%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): โ‚น52.79

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น58.61. an increase over its 2024 EPS that were of โ‚น42.32.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025โ‚น48.4614.5%
2024โ‚น42.3229.29%
2023โ‚น32.7323.09%
2022โ‚น26.5937.26%
2021โ‚น19.37-84.61%
2020โ‚น125.89-24.61%
2019โ‚น166.98-42.06%
2018โ‚น288.2040.7%
2017โ‚น204.84146.26%
2016โ‚น83.18-120.48%
2015-โ‚น406.073231.32%
2014-โ‚น12.19-115.78%
2013โ‚น77.24-23.36%
2012โ‚น100.78-48.01%
2011โ‚น193.85-9.68%
2010โ‚น214.6413.72%
2009โ‚น188.7424.32%
2008โ‚น151.82-6.05%
2007โ‚น161.6081.77%
2006โ‚น88.90-16.76%
2005โ‚น106.80-17.58%
2004โ‚น129.59